Analysis of 52 240 source plasma donors of convalescent <scp>COVID</scp> ‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation-Reference-Cited by-同舟云学术

Analysis of 52 240 source plasma donors of convalescent COVID ‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation

Published:2022-07-11 Issue:5 Volume:37 Page:449-459
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J of Clinical Apheresis

Author:

Schmidt Amy E.¹,Vogel Peter²,Chastain Carrie A.¹,Barnes Thomas³,Roth Nathan J.³,Simon Toby L.¹

Affiliation:

1. CSL Plasma Boca Raton Florida USA

2. CSL Behring Innovation Marburg Germany

3. CSL Behring Bern Switzerland

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21998

Reference53 articles.

1. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19

2. Convalescent plasma for patients with COVID-19

3. Effectiveness of convalescent plasma therapy in severe COVID-19 patients

4. The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

5. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating incidence of and factors associated with SARS-CoV-2 infection over a nine-month period in a highly-vaccinated healthcare worker cohort;QJM: An International Journal of Medicine;2024-05-17

3. A novel highly specific biotinylated MAC-ELISA for detection of anti-SARS-CoV-2 nucleocapsid antigen IgM antibodies during the acute phase of COVID-19;Brazilian Journal of Microbiology;2023-11-06

4. Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China;Frontiers in Immunology;2023-06-14

5. A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy;PLOS Pathogens;2023-01-27